BAT’s modern oral portfolio increases 74% in a year

BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment...
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*